Boston (Massachussetts), June 5, 2023 – At the 2023 BIO International Convention BIOQuébec and MassBio agreed to extend their existing memorandum of cooperation and collaboration for a 3-year period. This agreement, originally initiated in 2017 and renewed in 2019 at the same conference aims to facilitate business ties between their respective members and support the market development initiatives of both Québec and Massachusetts-based biotechnology sector companies.
Read MoreBIOQuébec is proud to be organizing, in partnership with Investissement Québec International, the Quebec CROs mission during MassBio’s State of Possible Conference, being held from May 4 to 6.
Read MoreWhile participating in the BIO International Convention, BIOQuébec and MassBio, which has more than 1,100 member companies, agreed to extend their existing partnership for a 3-year period.
Read MoreAn initiative to grow Western Australia’s life sciences and innovation sector and boost local research capability was announced today as part of a collaboration between the State Government, The University of Western Australia and MTPConnect.
GSK and NEOMED are calling on Quebec-based researchers to submit their innovative projects in early drug discovery for potential funding under the GSK and NEOMED $2 million Discovery Fund.
Read MoreTo repair a defect in the genome of an organism, one would have to remove, alter, or insert a genetic code at atomically precise locations in the DNA sequence. This vision is now a reality with CRISPR-Cas9, a nanotool that opens a door towards curing hereditary diseases and boosting agriculture.
Read More"Our investment in this program, and partnership with BC Tech, is pivotal in advancing entrepreneurship, and simultaneously supporting growth for BC-based companies," says Dr. Tony Brooks, Chief Financial Officer and Vice President, Entrepreneurship and Commercialization.
Read MoreThe bill (H 4501) provides about $463 million in new capital authorizations for the state Life Sciences Capital Fund
Read MoreAcquisition Expands Lilly Oncology Pipeline with Early-Phase Asset Being Studied in Multiple Tumor Types
Read MoreAccording to Hays in Singapore, the unexpected GDP growth in 2017 plus the strong and stable growth predicted for this year, means there is rise in demand for candidates in the commercial sectors and manufacturing parts of the life sciences industry. The growth is also being fuelled by the industry’s attention to the arrival of digital health and AI.
Read MoreLiving standards in the United States increasingly depend on the competitiveness of industries that compete internationally, particularly those that succeed by producing new innovations. The life-science sector, which includes pharmaceuticals, biotechnology, and medical devices, is one of those industries.
Read MoreBy the 30th of March 2019, the UK will officially exit the EU, in a move that is popularly known as Brexit. With this date fast approaching, companies, organizations and individuals all over the world have speculated about how Brexit might impact them.
Read MoreBig Data Plus Machine Learning Equals Scientific Advancement
Read MoreMassBio’s 2018 Annual Meeting - Building tomorrow's life sciences industry together.
Read MoreMassBio’s 2017 Annual Meeting is this week! Will you be attending?
Read More
